跳至主要内容
临床试验/ACTRN12608000307303
ACTRN12608000307303已完成3 期

A randomised, controlled comparison of uridine, pravastatin or uridine plus pravastatin to accelerate recovery of lipoatrophy in Human immunodeficiency virus (HIV)-infected adults

St Vincent's Hospital , Sydney0 个研究点目标入组 40 人开始时间: 2008年6月30日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. subcutaneous lipoatrophy in at least 2 body sites, at least one of which is moderate or severe according to both the patient and the doctor
  • 2. HIV viral load <50 copies /ml plasma for at least 3 months
  • 3. use of stable HARRT not including tNRTI for at least 3 months
  • 4. no grade 3or 4 laboratory values at baseline

排除标准

  • 1. zidovudine (AZT) or stavudine (d4T) in preceding 12 weeks (12/52)
  • 2. ongoing opportunistic infection , other AIDS -defining illness or other illness that would interfere with participation
  • 3. clinically significant renal or hepatic disease
  • 4.lipid levels necessitating statin treatment
  • 5. anabolic steriods, growth hormone, or supra-physiological corticosteriod doeses.
  • 6. pregnancy or breast feeding
  • 7. allergy to any component of the randomised drugs
  • 8. prior use of uridine

研究者

发起方
St Vincent's Hospital , Sydney

相似试验

A randomised, controlled comparison of uridine,... | 临床试验